Silvia Zai

937 total citations
8 papers, 170 citations indexed

About

Silvia Zai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Silvia Zai has authored 8 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Silvia Zai's work include Occupational and environmental lung diseases (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Pleural and Pulmonary Diseases (2 papers). Silvia Zai is often cited by papers focused on Occupational and environmental lung diseases (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Pleural and Pulmonary Diseases (2 papers). Silvia Zai collaborates with scholars based in Italy and United States. Silvia Zai's co-authors include Mario Botta, B. Castagneto, Andrea Ardizzoni, Luca Fumagalli, Luciano Mutti, Antonio Lazzaro, E. Piccolini, Ruggero Ridolfi, S. Bretti and Gianmauro Numico and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Lung Cancer.

In The Last Decade

Silvia Zai

8 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia Zai Italy 5 118 45 36 14 14 8 170
Olivia Lauk Switzerland 9 137 1.2× 47 1.0× 26 0.7× 17 1.2× 17 1.2× 38 219
Sae Wada Japan 8 130 1.1× 56 1.2× 16 0.4× 4 0.3× 7 0.5× 23 180
Elisabetta Casalone Italy 7 93 0.8× 28 0.6× 10 0.3× 11 0.8× 15 1.1× 14 159
Norihito Omote Japan 9 129 1.1× 51 1.1× 17 0.5× 3 0.2× 16 1.1× 20 226
Takashi Kiyokawa Japan 10 208 1.8× 34 0.8× 152 4.2× 3 0.2× 33 2.4× 26 358
Hữu Vĩnh Vũ Vietnam 7 53 0.4× 37 0.8× 51 1.4× 7 0.5× 46 3.3× 16 150
Yasuhide Takeuchi Japan 5 57 0.5× 22 0.5× 42 1.2× 2 0.1× 13 0.9× 28 115
Kevin Rhee United States 5 75 0.6× 38 0.8× 28 0.8× 3 0.2× 7 0.5× 7 153
Monika Wolf Germany 5 45 0.4× 87 1.9× 21 0.6× 10 0.7× 5 0.4× 10 164
Marcelo Luiz Balancin Brazil 9 51 0.4× 46 1.0× 8 0.2× 5 0.4× 11 0.8× 20 136

Countries citing papers authored by Silvia Zai

Since Specialization
Citations

This map shows the geographic impact of Silvia Zai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Zai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Zai more than expected).

Fields of papers citing papers by Silvia Zai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Zai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Zai. The network helps show where Silvia Zai may publish in the future.

Co-authorship network of co-authors of Silvia Zai

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Zai. A scholar is included among the top collaborators of Silvia Zai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Zai. Silvia Zai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Porta, Camillo, Elena Verzoni, Silvia Zai, et al.. (2020). Use of a natural multicomponent mouthwash plus oral hygiene vs oral hygiene alone to prevent everolimus-induced stomatitis: the STOP multicenter, randomized trial. Tumori Journal. 106(3). 257–266. 2 indexed citations
2.
Hollander, Lital, Diego Cortinovis, Irene Floriani, et al.. (2015). ATREUS Trial: A Phase II Study On The Activity Of Trabectedin In Pretreated Epithelioid Or Biphasic/Sarcomatoid Malignant Pleural Mesothelioma (MPM). Annals of Oncology. 26. vi87–vi87. 1 indexed citations
3.
Cortinovis, Diego, Lital Hollander, Irene Floriani, et al.. (2015). Activity and Safety of Trabectedin in patients with Sarcomatoid / Biphasic Malignant Pleural Mesothelioma (MPM). Annals of Oncology. 26. vi75–vi75. 1 indexed citations
4.
Grosso, Federica, Sara Orecchia, Silvia Zai, et al.. (2013). Double KRAS and BRAF mutations in colorectal cancer in a single oncologic department series.. Journal of Clinical Oncology. 31(15_suppl). e14657–e14657. 5 indexed citations
5.
Castagneto, B., et al.. (2005). Cisplatin and Gemcitabine in Malignant Pleural Mesothelioma: A Phase II Study. American Journal of Clinical Oncology. 28(3). 223–226. 44 indexed citations
7.
Castagneto, B., Silvia Zai, Luciano Mutti, et al.. (2001). Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion. Lung Cancer. 31(2-3). 303–310. 67 indexed citations
8.
Alabiso, Oscar, Maurizio Grosso, Isabella Chiappino, et al.. (2000). Intra-Arterial Continuous Infusion for Treatment of Pancreatic and Biliary Tract Cancer: A Dose-Escalation Study of Fluorouracil Combined with Gemcitabine. International Journal of Gastrointestinal Cancer. 27(3). 225–234. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026